ABT-737: Redefining Intrinsic Apoptosis Pathways in Cance...
2025-10-19
Explore how ABT-737, a leading small molecule BCL-2 protein inhibitor, uniquely intersects mitochondrial apoptosis with RNA Pol II signaling. Discover new scientific insights that distinguish this BH3 mimetic inhibitor in cancer cell research.